Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P KEANEY

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Bioorganic & Medicinal Chemistry Letters|July 29, 2014
2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replicationErin P Keaney, Michael Connolly, Markus Dobler, et al.
American Journal of Ophthalmology|August 9, 2005
Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine puriteNancy J Newman, Valerie Biousse, Robert David, et al.
Folia Histochemica Et Cytobiologica|December 31, 2005
The marrow cell continuum: stochastic determinismP Quesenberry, M Abedi, M Dooner, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in VivoAyako Honda, Edmund Harrington, Ivan Cornella-Taracido, et al.
Leukemia|September 7, 2018
Targeting quiescent leukemic stem cells using second generation autophagy inhibitorsPablo Baquero, Amy Dawson, Arunima Mukhopadhyay, et al.
Nature Communications|November 29, 2017
Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolismBenoit Bilanges, Samira Alliouachene, Wayne Pearce, et al.
Journal of Medicinal Chemistry|January 21, 2020
Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS DisordersSimone Bonazzi, Carleton P Goold, Audrey Gray, et al.
Journal of Medicinal Chemistry|July 3, 2023
Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS SyndromesSimone Bonazzi, Audrey Gray, Noel M Thomsen, et al.
Nature Cell Biology|October 21, 2014
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivoWilliam E Dowdle, Beat Nyfeler, Jane Nagel, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Bioorganic & Medicinal Chemistry Letters|July 29, 2014
2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replicationErin P Keaney, Michael Connolly, Markus Dobler, et al.
American Journal of Ophthalmology|August 9, 2005
Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine puriteNancy J Newman, Valerie Biousse, Robert David, et al.
Folia Histochemica Et Cytobiologica|December 31, 2005
The marrow cell continuum: stochastic determinismP Quesenberry, M Abedi, M Dooner, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in VivoAyako Honda, Edmund Harrington, Ivan Cornella-Taracido, et al.
Leukemia|September 7, 2018
Targeting quiescent leukemic stem cells using second generation autophagy inhibitorsPablo Baquero, Amy Dawson, Arunima Mukhopadhyay, et al.
Nature Communications|November 29, 2017
Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolismBenoit Bilanges, Samira Alliouachene, Wayne Pearce, et al.
Journal of Medicinal Chemistry|January 21, 2020
Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS DisordersSimone Bonazzi, Carleton P Goold, Audrey Gray, et al.
Journal of Medicinal Chemistry|July 3, 2023
Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS SyndromesSimone Bonazzi, Audrey Gray, Noel M Thomsen, et al.
Nature Cell Biology|October 21, 2014
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivoWilliam E Dowdle, Beat Nyfeler, Jane Nagel, et al.
Pageof 6